PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis • Value chain analysis PART 04: MARKET SIZING • Market definition • Market sizing 2019 • Market size and forecast 2019-2024 • Market outlook PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Pharmaceutical companies - Market size and forecast 2019-2024 • Other organizations - Market size and forecast 2019-2024 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2019-2024 • Europe - Market size and forecast 2019-2024 • Asia - Market size and forecast 2019-2024 • ROW - Market size and forecast 2019-2024 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Advent of AI in clinical research • Increasing outsourcing activities to CROs • Increasing adoption of cloud technologies in pharmaceutical production • and testing PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bilcare Ltd. • Caligor Coghlan Pharma Services • Corden Pharma International GmbH • Mawdsley-Brooks & Co. Ltd. • PCI Pharma Services • Piramal Enterprises Ltd. • Sentry BioPharma Services • Sharp • The WestRock group • Thermo Fisher Scientific Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Vendors: Key offerings Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: End-user - Market share 2019-2024 (%) Exhibit 19: Comparison by end-user Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions) Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%) Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions) Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%) Exhibit 24: Market opportunity by end-user Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2019-2024 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions) Exhibit 29: North America - Year-over-year growth 2020-2024 (%) Exhibit 30: Top 3 countries in North America Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions) Exhibit 32: Europe - Year-over-year growth 2020-2024 (%) Exhibit 33: Top 3 countries in Europe Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions) Exhibit 35: Asia - Year-over-year growth 2020-2024 (%) Exhibit 36: Top 3 countries in Asia Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions) Exhibit 38: ROW - Year-over-year growth 2020-2024 (%) Exhibit 39: Top 3 countries in ROW Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Impact of drivers and challenges Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Bilcare Ltd. - Vendor overview Exhibit 49: Bilcare Ltd. - Business segments Exhibit 50: Bilcare Ltd. - Key offerings Exhibit 51: Bilcare Ltd. - Key customers Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview Exhibit 53: Caligor Coghlan Pharma Services - Business segments Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments Exhibit 55: Caligor Coghlan Pharma Services - Key offerings Exhibit 56: Caligor Coghlan Pharma Services - Key customers Exhibit 57: Corden Pharma International GmbH - Vendor overview Exhibit 58: Corden Pharma International GmbH - Business segments Exhibit 59: Corden Pharma International GmbH - Organizational developments Exhibit 60: Corden Pharma International GmbH - Key offerings Exhibit 61: Corden Pharma International GmbH - Key customers Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers Exhibit 67: PCI Pharma Services - Vendor overview Exhibit 68: PCI Pharma Services - Business segments Exhibit 69: PCI Pharma Services - Organizational developments Exhibit 70: PCI Pharma Services - Key offerings Exhibit 71: PCI Pharma Services - Key customers Exhibit 72: Piramal Enterprises Ltd. - Vendor overview Exhibit 73: Piramal Enterprises Ltd. - Business segments Exhibit 74: Piramal Enterprises Ltd. - Organizational developments Exhibit 75: Piramal Enterprises Ltd. - Segment focus Exhibit 76: Piramal Enterprises Ltd. - Key offerings Exhibit 77: Piramal Enterprises Ltd. - Key customers Exhibit 78: Sentry BioPharma Services - Vendor overview Exhibit 79: Sentry BioPharma Services - Business segments Exhibit 80: Sentry BioPharma Services - Key offerings Exhibit 81: Sentry BioPharma Services - Key customers Exhibit 82: Sharp - Vendor overview Exhibit 83: Sharp - Business segments Exhibit 84: Sharp - Organizational developments Exhibit 85: Sharp - Geographic focus Exhibit 86: Sharp - Key offerings Exhibit 87: Sharp - Key customers Exhibit 88: The WestRock group - Vendor overview Exhibit 89: The WestRock group - Business segments Exhibit 90: The WestRock group - Organizational developments Exhibit 91: The WestRock group - Segment focus Exhibit 92: The WestRock group - Key offerings Exhibit 93: The WestRock group - Key customers Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 95: Thermo Fisher Scientific Inc. - Business segments Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings Exhibit 100: Thermo Fisher Scientific Inc. - Key customers Exhibit 101: Validation techniques employed for market sizing Exhibit 102: Definition of market positioning of vendors

Bilcare Ltd., Caligor Coghlan Pharma Services, Corden Pharma International GmbH, Mawdsley-Brooks & Co. Ltd., PCI Pharma Services, Piramal Enterprises Ltd., Sentry BioPharma Services, Sharp, The WestRock group, and Thermo Fisher Scientific Inc.